Science Inspired by
The Power of Nature
We’re using innovative biomaterials derived from silk proteins to deliver vaccines and therapeutics far beyond healthcare settings.
Silk Fibroin Biomaterials
Prized for its unique properties including stiffness and high tensile strength, silk has been used for millennia to make textiles. Now, Vaxess is adapting this ancient material to a new context, harnessing a key structural component of silk—fibroin proteins—to create advanced biomaterials that are strong, stable, and compatible with life-saving pharmacological compounds.
Engineering Advanced Biomaterials
Originally conceived at MIT and Tufts University, our pioneering utilization of silk fibroin proteins creates advanced biomaterials that are strong, stable, and biocompatible.
After gently extracting silk fibroin proteins from natural silk fibers, we use engineering processes to load vaccines and therapeutics. Flexible manufacturing lines at commercial scale are being supported by current grant from BARDA.
When applied to the skin through Vaxess’s MIMIX™ sustained release patch, these pharmaceutical-loaded biomaterials dissolve gradually in the body, enabling highly effective medicinal delivery and a more sustained immune response.
A Customized, Protective Microenvironment
Silk fibroin is inherently stable, simplifying the shipping and storage of sensitive treatments and able to protect sensitive compounds during extended release at body temperature. At Vaxess, we fine-tune these properties to achieve the most effective delivery profiles of various medicines and vaccines.
Innovation and Sustainability: solutions for those most in need
Livio Valenti, Vaxess Co-founder, Senior VP of Strategy, Operations and Business Development
Silk, the ancient material of the future
Fiorenzo Omenetto, Vaxess' Scientific Co-Founder